Notably, XSB treatment significantly increased BDNF levels and enhanced synaptic density in the hippocampal CA1 region (Figure 9), suggesting that XSB may mitigate synaptic dysfunction and cognitive decline in AD by restoring synaptic integrity and neurotrophic support. This evidence concerns the gene BDNF and Alzheimer disease.